Color Broadens Cancer Expert Medical Opinion Program
Color expanded its Expert Medical Opinion program with a new peer-to-peer service that connects oncologists with cancer specialists.
Color expanded its Expert Medical Opinion program with a new peer-to-peer service that connects oncologists with cancer specialists.
Evernorth is investing $100 million through 2028 in Pharmacy Forward, an AI-powered program aimed at improving specialty pharmacy operations and patient care.
In this episode, we’re joined by Dr. Cathleen Brown, medical director of menopause company Winona. We discuss the company’s new Winona Research Initiative, which seeks to fund and support menopause and women's health research.
Zelis has introduced an AI solution to help health insurers streamline the No Surprises Act's Independent Dispute Resolution process.
Health tech companies made several major funding announcements in June. Here is a list of some of the biggest funding rounds.
CMS is recalculating some 2026 Medicare Advantage Star Ratings after a court ruled it improperly calculated Clover Health's rating, a decision that could boost payments for a small number of insurers.
The Medicare Cost Cap Act seeks to create a $5,000 cap on out-of-pocket costs for traditional Medicare beneficiaries.
Upside's $20 million raise was led by Aquiline and Flare Capital Partners, with support from existing investors including 645 Ventures, Freestyle Capital, Triple Impact Capital and Techstars.
Priority Health is partnering with Garner Health to steer members to high-quality physicians and reduce healthcare costs for employers.
Ladder Health's seed round was led by Nina Capital, with participation from Mairs & Power Venture Capital, South Dakota First Capital, 25madison Health, Hatteras Venture Partners, Create Health Ventures, Jumpstart Capital, White Oak Enterprises, Groove Capital and 7Rock Ventures.
Abarca Health and LucyRx plan to combine to build a larger independent PBM serving more than 9 million members.
Congressional Democrats are seeking to repeal the controversial WISeR model, but experts are unsure if their efforts will succeed.
Through a new partnership, Marathon employer clients who don’t currently offer Lantern’s specialty care benefit can purchase it directly through Marathon.
KFF’s analysis found that the average number of issuers offering plans on the Marketplaces declined to 9 issuers per state in 2026, compared to 9.6 issuers per state in 2025.
InStride's Series C round includes support from new investors Echo Health Ventures and FMZ Ventures, as well as existing investors .406 Ventures, Valtruis, General Catalyst and Mass General Brigham Ventures.